| Name | Title | Contact Details |
|---|
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
Biosculpture Technology is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Management Associates is a for-profit corporation which operates hospitals and other health care facilities in the southern United States. It is headquartered at 5811 Pelican Bay Blvd. in North Naples, Florida. Its current CEO is Gary D. Newsome. Serving on the board of directors are William Schoen, Pascal Goldschmidt, Donald Kiernan, William Steere, Vicki O'Meara, Robert Knox, Kent Dauten and Randolph W. Westerfield. Health Management Associates (HMA) is an organization that provides people, processes, capital, and subject matter expertise to hospitals and physician practices per their individual needs or governing requirements (1). Additional functions that HMA provides to hospitals and provider groups are to invest capital for renewal of hospital facilities, recruiting of physicians to expand community resources or hospital services, and promote the use standardized best practices throughout HMA facilities.
DisperSol Technologies provides expertise in formulation and processing technologies for solubility/bioavailability enhancement of poorly water-soluble drug molecules.
Your vision. Our resources. Together we can build a bright future for your practice and the veterinary industry as a whole.